Cranial and non-cranial embolism: Incidence in hospitalised patients in Germany

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 4, 2013, Pages 369-374

  Moysidis, Theodoros ^a   Santosa, Frans ^a   Stallinger, Christian ^a   Kröger, Knut ^a  

^a HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

Embolic event; Embolic stroke; Gender; Systemic embolisms

Indexed keywords

APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

ADULT; AGED; ARTERY EMBOLISM; ARTICLE; BRAIN EMBOLISM; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMBOLISM; FEDERAL STATISTICAL OFFICE; FEMALE; GERMANY; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-10; INCIDENCE; LOWER LIMB EMBOLISM; MALE; ORGANIZATION; PRIORITY JOURNAL; SYSTEMIC EMBOLISM; THROMBOSIS; TREND STUDY; UPPER LIMB EMBOLISM;

FEMALE; GERMANY; HOSPITALIZATION; HUMANS; INCIDENCE; INTRACRANIAL EMBOLISM; MALE; RETROSPECTIVE STUDIES; STROKE;

EID: 84889087898     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0873-4     Document Type: Article

References (19)

1. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kääb S, Schotten U, Wegscheider K, Boriani G, Ezekowitz M, Diener H, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Vardas P, Breithardt G, Camm AJ (2011) Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. Executive summary of the report from the III AFNET/EHRA consensus conference. Thromb Haemost 106:1012-1019
2. Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Marín F, Consensus Document of European Society of Cardiology Working Group on Thrombosis (2010) Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 31:1311-1318
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
4. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981-992
5. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883-891
6. Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC (2011) The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace 13:1375-1385
7. Rich MW (2009) Epidemiology of atrial fibrillation. J Interv Card Electrophysiol 25:3-8
8. Hughes M, Lip GY (2008) Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical ExcellenceStroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 99:295-304
9. Saric M, Kronzon I (2012) Aortic Atherosclerosis and Embolic Events. Curr Cardiol Rep 14(3):342-349
10. O'Connell JB, Quiñones-Baldrich WJ (2009) Proper evaluation and management of acute embolic versus thrombotic limb ischemia. Semin Vasc Surg 22:10-16
11. Walker TG (2009) Acute limb ischemia. Tech Vasc Interv Radiol 12:117-129
12. Sultan S, Evoy D, Eldin AS, Eldeeb M, Elmehairy N (2001) Atraumatic acute upper limb ischemia: a series of 64 patients in a middle east tertiary vascular center and literature review. Vasc Surg 35:181-197
13. Pereira Barretto AC, Nobre MR, Mansur AJ, Scipioni A, Ramires JA (2000) Peripheral arterial embolism. Report of hospitalized cases. Arq Bras Cardiol 74:324-328
14. Karapolat S, Dag O, Abanoz M, Aslan M (2006) Arterial embolectomy: a retrospective evaluation of 730 cases over 20 years. Surg Today 36:416-419
15. Hu HD, Chang Q, Chen Z, Liu C, Ren YY, Cai YC, Zhang J, Xin SJ (2011) Management and prognosis of acute arterial embolism: a multivariable analysis of 346 patients. Zhonghua Yi Xue Za Zhi 91:2923-2926
16. Magishi K, Izumi Y, Shimizu N (2010) Short- and long-term outcomes of acute upper extremity arterial thromboembolism. Ann Thorac Cardiovasc Surg 16:31-34
17. Gossage JA, Ali T, Chambers J, Burnand KG (2006) Peripheral arterial embolism: prevalence, outcome, and the role of echocardiography in management. Vasc Endovascular Surg 40:280-286
18. Tofigh AM, Karvandi M, Coscas R (2008) Current incidence of peripheral arterial embolism and role of echocardiography. Asian Cardiovasc Thorac Ann 16:439-443
19. Stausberg J (2007) Quality of coding in acute inpatient care. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:1039-1046